Eli Lilly and Firm (LLY) This autumn 2024 Earnings Name Transcript
Eli Lilly and Firm (NYSE:LLY) This autumn 2024 Outcomes Convention Name February 6, 2025 10:00 AM ET
Firm Individuals
Mike Czapar – Senior Vice President of Investor Relations
David Ricks – Chair and CEO
Lucas Montarce – Chief Monetary Officer
Dr. Dan Skovronsky – Chief Scientific Officer & President of Lilly Immunology
Patrik Jonsson – President of Lilly Cardiometabolic Well being & Lilly USA
Dave Hyman – Chief Medical Officer
Anne White – President of Lilly Neuroscience
Jake Van Naarden – President of Lilly Oncology
Ilya Yuffa – President of Lilly Worldwide
Marc Kemen – Investor Relations
Wes Taul – Investor Relations
Wai Wong – Investor Relations
Convention Name Individuals
Tim Anderson – Financial institution of America
Terence Flynn – Morgan Stanley
Courtney Breen – Bernstein
Chris Schott – JPMorgan
Geoff Meacham – Citibank
Colleen Garvey – Guggenheim Securities
Conor MacKay – BMO Capital Markets
Umer Raffat – Evercore
Steve Scala – TD Cowen
Mohit Bansal – Wells Fargo
Dave Risinger – Leerink Companions
Akash Tewari – Jefferies
Alexandria Hammond – Wolfe Analysis
Chris Shibutani – Goldman Sachs
James Shin – Deutsche Financial institution
Trung Huynh – UBS
Nicole Germino – Truist Securities
Operator
Girls and gents, thanks for standing by, and welcome to the Lilly This autumn 2024 Earnings Name. At the moment all contributors are in a listen-only mode. [Operator Instructions]
I might now like to show the convention over to your host, Mike Czapar, Senior Vice President of Investor Relations. Mike, please go forward.
Mike Czapar
Good morning, thanks for becoming a member of us for Eli Lilly and Firm’s This autumn 2024 earnings name. I am Mike Czapar, Senior Vice President of Investor Relations.
Becoming a member of me on right this moment’s name are David Ricks, Lilly’s Chair and CEO; Dr. Dan Skovronsky, Chief Scientific Officer and President of Lilly Immunology; Lucas Montarce, Chief Monetary Officer; Anne White, President of Lilly Neuroscience; Ilya Yuffa, President of Lilly Worldwide; Jake
